Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 22/03/22 → 29/06/25 |
Keywords
- Neurological diseases
- Migraine headache
- Clinical trial
Clinical Trial Phase
- Phase II
A Randomized, Multicenter, Dose-Blinded, Phase 2 Extension Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache.
- Ray, Jason (Primary Chief Investigator (PCI))
- Kraemer, Thomas (Chief Investigator (CI))
- Cordato, Dennis John (Chief Investigator (CI))
Project: Research